journal article·2022-08Open access

Immunogenic Cell Death Activates the Tumor Immune Microenvironment to Boost the Immunotherapy Efficiency

Zhilin Li, Xiaoqin Lai, Shiqin Fu, Long Ren, Hao Cai, Hu Zhang, Zhongwei Gu, Xuelei Ma, Kui Luo

Advanced Science· Volume 9· Issue 22

Abstract

Abstract Tumor immunotherapy is only effective in a fraction of patients due to a low response rate and severe side effects, and these challenges of immunotherapy in clinics can be addressed through induction of immunogenic cell death (ICD). ICD is elicited from many antitumor therapies to release danger associated molecular patterns (DAMPs) and tumor‐associated antigens to facilitate maturation of dendritic cells (DCs) and infiltration of cytotoxic T lymphocytes (CTLs). The process can reverse the tumor immunosuppressive microenvironment to improve the sensitivity of immunotherapy. Nanostructure‐based drug delivery systems (NDDSs) are explored to induce ICD by incorporating therapeutic molecules for chemotherapy, photosensitizers (PSs) for photodynamic therapy (PDT), photothermal conversion agents for photothermal therapy (PTT), and radiosensitizers for radiotherapy (RT). These NDDSs can release loaded agents at a right dose in the right place at the right time, resulting in greater effectiveness and lower toxicity. Immunotherapeutic agents can also be combined with these NDDSs to achieve the synergic antitumor effect in a multi‐modality therapeutic approach. In this review, NDDSs are harnessed to load multiple agents to induce ICD by chemotherapy, PDT, PTT, and RT in combination of immunotherapy to promote the therapeutic effect and reduce side effects associated with cancer treatment.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Nanoplatforms for cancer theranostics · Immunotherapy and Immune Responses · Cancer Immunotherapy and Biomarkers

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Department of Biotherapy Huaxi MR Research Center (HMRRC) Day Surgery Center Department of Radiology Cancer Center Research Core Facilities of West China Hospital National Clinical Research Center for Geriatrics Frontiers Science Center for Disease‐Related Molecular Network State Key Laboratory of Biotherapy West China Hospital Sichuan University Chengdu 610041 China

Amgen Bioprocessing Centre Keck Graduate Institute Claremont CA 91711 USA

Functional and Molecular Imaging Key Laboratory of Sichuan Province and Research Unit of Psychoradiology Chinese Academy of Medical Sciences Chengdu 610041 China

Funding

National Natural Science Foundation of China

References (100+)

Show source-provided references
1. 10.1038/s41573-018-0006-z10.1038/s41573-018-0006-z ↗
2. 10.1038/s41423-020-0488-610.1038/s41423-020-0488-6 ↗
3. 10.1126/science.aar406010.1126/science.aar4060 ↗
4. 10.1016/j.jconrel.2021.08.02010.1016/j.jconrel.2021.08.020 ↗
5. 10.1002/adfm.20210463010.1002/adfm.202104630 ↗
6. 10.1038/nature1067310.1038/nature10673 ↗
7. 10.1038/s41578-019-0108-110.1038/s41578-019-0108-1 ↗
8. 10.1126/science.aaa817210.1126/science.aaa8172 ↗
9. 10.1038/nrc.2016.3610.1038/nrc.2016.36 ↗
10. 10.1016/j.cell.2017.01.01710.1016/j.cell.2017.01.017 ↗
11. 10.1056/NEJMoa130513310.1056/NEJMoa1305133 ↗
12. 10.1200/JCO.2015.60.844810.1200/JCO.2015.60.8448 ↗
13. 10.1038/s41571-019-0218-010.1038/s41571-019-0218-0 ↗
14. 10.1001/jamaoncol.2018.392310.1001/jamaoncol.2018.3923 ↗
15. 10.1038/nri.2017.4910.1038/nri.2017.49 ↗
16. 10.1021/acs.accounts.9b0014810.1021/acs.accounts.9b00148 ↗
17. 10.1126/sciadv.aao173610.1126/sciadv.aao1736 ↗
18. 10.1038/nrclinonc.2015.20910.1038/nrclinonc.2015.209 ↗
19. 10.1038/nrc338010.1038/nrc3380 ↗
20. 10.1038/s41590-022-01132-210.1038/s41590-022-01132-2 ↗
21. 10.1096/fj.09-14548210.1096/fj.09-145482 ↗
22. 10.1038/emboj.2009.110.1038/emboj.2009.1 ↗
23. 10.1038/sj.cdd.440220110.1038/sj.cdd.4402201 ↗
24. 10.1038/nm152310.1038/nm1523 ↗
25. 10.1126/science.120834710.1126/science.1208347 ↗
26. 10.1038/nature0829610.1038/nature08296 ↗
27. 10.1186/s40425-018-0360-810.1186/s40425-018-0360-8 ↗
28. 10.1111/j.1600-065X.2007.00573.x10.1111/j.1600-065X.2007.00573.x ↗
29. 10.1186/1479-5876-12-21110.1186/1479-5876-12-211 ↗
30. 10.1080/0265673090283567210.1080/02656730902835672 ↗
31. 10.1016/j.jss.2006.06.00310.1016/j.jss.2006.06.003 ↗
32. 10.1038/s12276-022-00736-w10.1038/s12276-022-00736-w ↗
33. 10.1146/annurev-immunol-032712-10000810.1146/annurev-immunol-032712-100008 ↗
34. 10.1016/j.biomaterials.2021.12112010.1016/j.biomaterials.2021.121120 ↗
35. 10.1002/anie.20211051210.1002/anie.202110512 ↗
36. 10.1016/j.cyto.2017.05.02410.1016/j.cyto.2017.05.024 ↗
37. 10.1038/s41401-020-0400-z10.1038/s41401-020-0400-z ↗
38. 10.1002/anie.20180488210.1002/anie.201804882 ↗
39. 10.4161/tisb.2952810.4161/tisb.29528 ↗
40. 10.1126/science.122633810.1126/science.1226338 ↗
41. 10.1038/s41568-019-0186-910.1038/s41568-019-0186-9 ↗
42. 10.1016/j.apsb.2020.12.01810.1016/j.apsb.2020.12.018 ↗
43. 10.1002/adma.20210804910.1002/adma.202108049 ↗
44. 10.1002/adfm.20211040810.1002/adfm.202110408 ↗
45. 10.1021/cr500419810.1021/cr5004198 ↗
46. 10.1002/smll.20180241710.1002/smll.201802417 ↗
47. 10.1038/s41565-022-01085-510.1038/s41565-022-01085-5 ↗
48. 10.7150/thno.1668410.7150/thno.16684 ↗
49. 10.1002/adma.20190415610.1002/adma.201904156 ↗
50. 10.1038/s41571-019-0308-z10.1038/s41571-019-0308-z ↗
51. 10.1038/s41577-019-0269-610.1038/s41577-019-0269-6 ↗
52. 10.1016/j.addr.2021.11390510.1016/j.addr.2021.113905 ↗
53. 10.1016/j.jconrel.2014.12.03010.1016/j.jconrel.2014.12.030 ↗
54. 10.1016/j.addr.2018.07.00810.1016/j.addr.2018.07.008 ↗
55. 10.1038/natrevmats.2016.1410.1038/natrevmats.2016.14 ↗
56. 10.1002/adma.20160662810.1002/adma.201606628 ↗
57. 10.1038/nrc.2016.10810.1038/nrc.2016.108 ↗
58. 10.1016/j.addr.2009.03.00910.1016/j.addr.2009.03.009 ↗
59. 10.1016/j.apsb.2021.03.03310.1016/j.apsb.2021.03.033 ↗
60. 10.1038/nnano.2013.18110.1038/nnano.2013.181 ↗
61. 10.1038/nbt.333010.1038/nbt.3330 ↗
62. 10.1248/bpb.b13-0005910.1248/bpb.b13-00059 ↗
63. 10.1093/annonc/mdf15710.1093/annonc/mdf157 ↗
64. 10.1016/j.jconrel.2009.02.02310.1016/j.jconrel.2009.02.023 ↗
65. 10.1016/j.jconrel.2007.12.01410.1016/j.jconrel.2007.12.014 ↗
66. 10.1002/advs.20210274110.1002/advs.202102741 ↗
67. 10.1016/j.cej.2021.13349810.1016/j.cej.2021.133498 ↗
68. Xiao G. · Clin. Transl. Oncol. · 2022 · 1
69. 10.1002/adma.20160164310.1002/adma.201601643 ↗
70. 10.1016/j.bioactmat.2022.01.03510.1016/j.bioactmat.2022.01.035 ↗
71. 10.1002/adma.20210459410.1002/adma.202104594 ↗
72. 10.1016/j.jconrel.2022.02.01310.1016/j.jconrel.2022.02.013 ↗
73. 10.1002/adhm.20120013810.1002/adhm.201200138 ↗
74. 10.1126/science.122956810.1126/science.1229568 ↗
75. 10.1002/adma.20180272510.1002/adma.201802725 ↗
76. 10.1016/j.apsb.2020.05.00810.1016/j.apsb.2020.05.008 ↗
77. 10.1016/j.apsb.2020.07.01310.1016/j.apsb.2020.07.013 ↗
78. 10.1016/S0168-3659(99)00248-510.1016/S0168-3659(99)00248-5 ↗
79. Matsumura Y. · Cancer Res. · 1986 · 46 · 6387
80. 10.1016/j.addr.2020.06.00510.1016/j.addr.2020.06.005 ↗
81. 10.1007/s00432-014-1767-310.1007/s00432-014-1767-3 ↗
82. 10.1016/j.addr.2018.08.00510.1016/j.addr.2018.08.005 ↗
83. 10.2217/fon.10.6710.2217/fon.10.67 ↗
84. 10.1016/j.apsb.2016.03.01010.1016/j.apsb.2016.03.010 ↗
85. 10.1517/14712598.8.8.106310.1517/14712598.8.8.1063 ↗
86. 10.1016/j.apsb.2020.10.00910.1016/j.apsb.2020.10.009 ↗
87. 10.1088/1361-6528/aa76cc10.1088/1361-6528/aa76cc ↗
88. 10.1016/j.apsb.2021.08.02110.1016/j.apsb.2021.08.021 ↗
89. 10.1016/j.actbio.2019.05.03410.1016/j.actbio.2019.05.034 ↗
90. 10.1016/j.jconrel.2020.09.01710.1016/j.jconrel.2020.09.017 ↗
91. 10.1016/j.ijpharm.2021.12141210.1016/j.ijpharm.2021.121412 ↗
92. 10.1016/j.addr.2012.10.01510.1016/j.addr.2012.10.015 ↗
93. 10.1038/nrc145610.1038/nrc1456 ↗
94. 10.1021/acsnano.8b0610410.1021/acsnano.8b06104 ↗
95. 10.1016/j.apsb.2020.04.01110.1016/j.apsb.2020.04.011 ↗
96. 10.1016/j.jconrel.2020.08.02410.1016/j.jconrel.2020.08.024 ↗
97. 10.1158/0008-5472.CAN-03-147210.1158/0008-5472.CAN-03-1472 ↗
98. 10.1016/j.jcis.2018.04.08410.1016/j.jcis.2018.04.084 ↗
99. 10.1021/nl900031y10.1021/nl900031y ↗
100. 10.1093/jnci/djj07010.1093/jnci/djj070 ↗